|
Market Closed -
Bombay S.E.
22:54:56 2026-11-08 EST
|
5-day change | 1st Jan Change | ||
| 111.00 INR | +0.91% |
|
+4.67% | -14.62% |
| Market Cap | 1.26B 13.44M 12.05M 11.02M 10.06M 18.95M 19.54M 133M 52.95M 674M 50.45M 49.37M 2.13B | P/E 2025 |
10.7x | P/E 2026 | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.07B 22.01M 19.74M 18.04M 16.47M 31.02M 32M 217M 86.7M 1.1B 82.6M 80.83M 3.48B | EV / Sales 2025 |
1.02x | EV / Sales 2026 | 0.92x |
| Free-Float |
14.66% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| PARNAXLAB | Delayed | |
NSE India S.E.
| PARNAXLAB | Delayed |
| 1 day | +0.91% | ||
| 1 week | +4.67% | ||
| Current month | +4.67% | ||
| 1 month | -5.13% | ||
| 3 months | -16.70% | ||
| 6 months | -31.63% | ||
| Current year | -14.62% |
| 1 week | 92.35 | 111 | |
| 1 month | 92.35 | 121 | |
| Current year | 92.35 | 182 | |
| 1 year | 92.35 | 182 | |
| 3 years | 75.6 | 193.5 | |
| 5 years | 24 | 193.5 | |
| 10 years | 11.65 | 193.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2024-07-04 | |
Binoy Baiju Shah
DFI | Director of Finance/CFO | 42 | 2024-07-04 |
| Compliance Officer | - | 2021-06-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Ami Mihir Shah
BRD | Director/Board Member | 50 | 2015-03-30 |
| Director/Board Member | 72 | 2021-05-27 | |
| Director/Board Member | 67 | 2023-08-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.91% | +4.67% | -11.69% | +26.14% | 12.47M | ||
| -0.79% | -4.48% | +46.48% | +118.69% | 1,206B | ||
| +1.43% | +1.11% | +48.05% | +83.72% | 665B | ||
| +1.07% | -1.21% | +32.92% | +105.10% | 515B | ||
| -0.36% | -3.25% | +45.42% | +63.89% | 381B | ||
| -0.14% | -1.87% | +70.06% | +40.55% | 362B | ||
| -0.78% | -0.52% | +30.47% | +56.79% | 307B | ||
| -0.80% | -0.21% | +7.98% | +36.97% | 289B | ||
| +0.03% | -1.20% | +43.79% | +68.49% | 249B | ||
| -0.41% | -2.22% | +40.43% | +114.24% | 207B | ||
| Average | +0.02% | -1.76% | +35.39% | +71.46% | 417.98B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +86.30% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.88B 19.98M 17.92M 16.37M 14.95M 28.16M 29.05M 197M 78.7M 1B 74.98M 73.37M 3.16B | 2.49B 26.45M 23.72M 21.68M 19.79M 37.28M 38.46M 261M 104M 1.33B 99.26M 97.13M 4.19B |
| Net income | 115M 1.23M 1.1M 1M 917K 1.73M 1.78M 12.11M 4.83M 61.46M 4.6M 4.5M 194M | 118M 1.25M 1.12M 1.03M 937K 1.77M 1.82M 12.38M 4.94M 62.84M 4.7M 4.6M 198M |
| Net Debt | 690M 7.34M 6.58M 6.01M 5.49M 10.34M 10.67M 72.5M 28.91M 368M 27.54M 26.95M 1.16B | 805M 8.57M 7.68M 7.02M 6.41M 12.08M 12.46M 84.63M 33.75M 430M 32.15M 31.46M 1.36B |
Employees
12
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-08 | ₹111.00 | +0.91% | 9 |
| 26-11-08 | ₹110.00 | +7.79% | 2 |
| 26-11-06 | ₹102.05 | -0.92% | 114 |
| 26-11-05 | ₹103.00 | +1.93% | 91 |
| 26-11-04 | ₹101.05 | -2.84% | 2,661 |
- Stock Market
- Stocks
- PARNAXLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















